プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Khalid S.に依頼

United Kingdom

Expert in CRISPR/Cas9, molecular and cell biology, organoid, immunology, precision cancer research

プロフィール概要

As Senior scientist,involved in a variety of genome-wide/bespoke library CRISPR based projects including immunology

専門分野

• ☆ Immunoassay
• ☆ Molecular Biology
• ☆ Genetics
• ☆ Genomics
• ☆ Molecular Cloning
• ☆ Next Generation Sequencing (NGS)
• ☆ DNA Sequencing
• ☆ Gene Expression Analysis
• ☆ Genome Sequencing
• ☆ Exome Sequencing
• ☆ Recombinant DNA
• ☆ RNA Sequencing
• ☆ DNA/Gene Synthesis
• ☆ Oligonucleotide Synthesis
• ☆ Plasmid DNA
• ☆ ChIP-Seq
• ☆ Cell Biology
• ☆ Cell-Based Assays
• ☆ Stem Cell Research
• ☆ Gene Editing/CRISPR
• ☆ Phylogenetics
• ☆ Drug Development
• ☆ Pharmacogenomics
• ☆ Immunogenetics
• ☆ Immunotherapy
• ☆ Cancer Research
• ☆ Cancer Biology
• ☆ Carcinogenesis
• ☆ Technical & Scientific Writing
• ☆ Manuscript & Journal Article Writing
• ☆ Experimental Protocols
• ☆ SOP & Protocol Writing
• ☆ Grant Writing

サービス

• Writing
• Research
• Consulting
• Data & AI

Writing Technical Writing

Research User Research, Scientific and Technical Research

Consulting Healthcare Consulting, Scientific and Technical Consulting

Data & AI Data Visualization

職務経験

Senior Scientist

Cancer Research UK Cambridge Research Institute

9月 2019 - 現在

Researcher

Helsingin Yliopisto

2月 2018 - 8月 2019

Postdoctoral Fellow

University of Helsinki

1月 2018 - 8月 2019

学歴

PhD (Institute for Molecular Medicine Finland FIMM)

University of Helsinki

3月 2010 - 8月 2018

認定資格

• 認定資格の詳細は未入力です。

出版物

PREPRINT

Khalid Saeed, Jun Dai, Shuyu Zheng, Matías M. Falco, Jie Bao, Johanna Eriksson, Fernando Perez-Villatoro, Anniina Färkkilä, Olli Dufva, Satu Mustjoki, et al. (2022). Tracing back primed resistance in cancer via sister cells .

JOURNAL ARTICLE

Khalid Saeed, Poojitha Ojamies, Teijo Pellinen, Samuli Eldfors, Riku Turkki, Johan Lundin, Petrus Järvinen, Harry Nisen, Kimmo Taari, Taija M. af Hällström, et al.(2019). Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells . International Journal of Cancer. Wiley

Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions.

comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancers.